Sangamo Therapeutics, Inc. announced changes to its research and development organization. Going forward, research and development will each be managed as separate functions. A search for a Head of Development is underway. Jason Fontenot, Senior Vice President, Cell Therapy, will assume the role of Interim Head of Research. The heads of research and development will report to CEO Sandy Macrae. Sangamo also announced the departure of Adrian Woolfson, Executive Vice President of R&D.